Gene · 1848
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neurogenetic mechanisms of risk for ADHD: Examining associations of polygenic scores and brain volumes in a population cohort. | J Neurodev Disord | 2023 | 37653373 | PubTator, text mining | PubMed |
| Spatial transcriptome atlas reveals pulmonary microstructure-specific COVID-19 gene signatures in cynomolgus macaques. | Commun Biol | 2023 | 37640792 | PubTator, text mining | PubMed |
| Insights into Sex and Gender Differences in Brain and Psychopathologies Using Big Data. | Life (Basel) | 2023 | 37629533 | PubTator, text mining | PubMed |
| Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations. | Thorac Cancer | 2023 | 37605791 | PubTator, text mining | PubMed |
| Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts. | Mol Oncol | 2023 | 37604687 | PubTator, text mining | PubMed |
| The integrated stress response in cancer progression: a force for plasticity and resistance. | Front Oncol | 2023 | 37601686 | PubTator, text mining | PubMed |
| Bioinformatics-based screening of key genes for transformation of tyrosine kinase inhibitor-resistant lung adenocarcinoma to small cell lung cancer. | Front Med (Lausanne) | 2023 | 37583423 | PubTator, text mining | PubMed |
| Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy. | Cancers (Basel) | 2023 | 37568739 | PubTator, text mining | PubMed |
| Anticancer therapeutic effect of ginsenosides through mediating reactive oxygen species. | Front Pharmacol | 2023 | 37564184 | PubTator, text mining | PubMed |
| Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy. | Nat Metab | 2023 | 37563469 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection perturbs enhancer mediated transcriptional regulation of key pathways. | PLoS Comput Biol | 2023 | 37561814 | PubTator, text mining | PubMed |
| Precision RNAi using synthetic shRNAmir target sites. | Elife | 2023 | 37552050 | PubTator, text mining | PubMed |
| SPRY4-dependent ERK negative feedback demarcates functional adult stem cells in the male mouse germline†. | Biol Reprod | 2023 | 37552049 | PubTator, text mining | PubMed |
| Editorial: Diverse roles of MAP4K4 in MAP kinase signaling and its implication for cancer therapeutics. | Front Oncol | 2023 | 37546416 | PubTator, text mining | PubMed |
| Differential Salmonella Typhimurium intracellular replication and host cell responses in caecal and ileal organoids derived from chicken. | Vet Res | 2023 | 37525204 | PubTator, text mining | PubMed |
| Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1. | Mol Ther Nucleic Acids | 2023 | 37520682 | PubTator, text mining | PubMed |
| An In Silico Study Investigating Camptothecin-Analog Interaction with Human Protein Tyrosine Phosphatase, SHP2 (PTPN11). | Pharmaceuticals (Basel) | 2023 | 37513838 | PubTator, text mining | PubMed |
| miRNAs as Modern Biomarkers in Asthma Therapy. | Int J Mol Sci | 2023 | 37511254 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication. | Cell Death Dis | 2023 | 37495592 | PubTator, text mining | PubMed |
| STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells. | Cell Death Dis | 2023 | 37479689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1848/papers?page=11